FDA Approves Orexigen's Weight-Loss Drug

The Wall Street Journal (online registration required): The U.S. Food and Drug Administration said it approved Orexigen Therapeutics Inc.'s weight-loss treatment Contrave, the third such drug to receive the agency's approval in recent years.

Contrave has been approved as a treatment for chronic weight management in addition to a reduced-calorie diet and physical activity, the FDA said Wednesday in a...

Read article